Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ADA 2026 5 - 8 June 2026

HbA1c and Weight Outcomes Among Adults With Type 2 Diabetes on 25-mg Oral Semaglutide Previously Treated With Metformin Only: A Post Hoc Analysis From PIONEER PLUS

Authors :

Lin Xie1; Chethana K. Ramesh2; Angelo Navas1,3; Chalak Muhammad1

Affiliations
View Details Hide Details
Download .PDF
Keywords
Diabetes
Congress poster
GLP-1 RA
Semaglutide (oral)
PHASE 3 (RCT)